31 / 94
31
Ces Urol 2015; 19(1): 19–32
PŘEHLEDOVÝ ČLÁNEK
8. Backes DM, Kurman RJ, Pimenta JM, et al.
Systematic review of human papilomavirus prevalence in
invasive penile cancer. Cancer causes Contro1 2009 May; 20(4): 449–457.
9. Michal M, Hes O, Kacerovska D, et al.
Klasifikace intraepiteliálních neoplazií předcházejících dlaždico-
vému karcinomu penisu a jejich analogie s prekancerózami dlaždicových karcinomů vulvy. Ces Urol 2014,
18(2): 94–100.
10. Lont AP, Kroon BK, Horenblas S, et al.
Presence of high risk human papilllomavirus DNA in penis
carcinoima predicts favorable outcome in surfoval. Int J Cancer 2006 Sep; 119(5): 1078–1081.
11. Bezerra AL, Lopes A, Santiago GH, et al.
Human papilomavirus as a prognostic factor in carcinoma
of penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer 2001
Jun; 91(12): 5–21.
12. Rubin MA, Kleter B, Zhou M, et al.
Detection and typing of human papillomavirus DNA in penile
carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001; 159:
1211–1218.
13. Schneider H, Sokol L, Valanský L, et al.
Verukózny karcinom penisu – zriedkavý variant dlaždicobun-
kového karcinómu. Ces Urol 2000; 4(2): 43–46.
14. Velazquez EF, Barreto JE, Rodriquez I, et al.
Limitations in the interpretation of biopsies in patiens
with penile squamous cell carcinoma. Int J Surg Pathol 2004 Apr; 12(2): 139–146.
15. TNM klasifikace zhoubných novotvarů.
7. vydání 2009 (česká verze 2011); ÚZIS 93–95.
16. Kayes O, MinhasS, AllenC, et al.
The role of magnetic resonance imaging in the local staging of penile
cancer. European Urology 2007; Vol 51(5): 1313–1319.
17. Hora M, Trávníček I, Kalusová K, et al.
Penis šetřící metody léčby nižších T kategorií karcinomu penisu
Ces Urol 2014, 18(3): 199–207.
18. Babjuk M, Novák J, Dvořáček J.
Nd: YAG Laser v léčbě povrchových lézí penisu Rozhledy Chir, 1998;
77: 497–499.
19. Alexiades-Armenakas MR, Dover JS, Arndt KA.
Fractional laser skin resurfacing. Journal Journal of
drugs in dermatology: JDD 2012; 11(11): 1274–1287.
20. Meijer RP, BoonTA, vanVenrooij GE, et al.
Long-term follow up after laser therapy for penile carcinoma.
Urology 2007 Apr; 69(4): 759–762.
21. Hora M, Pizinger K, Bursa V, et al.
Glansektomie v léčbě karcinomu penisu. Ces Urol 2011; 15(1): 15–23.
22. Hakenberg OW, Compérat E, Minhas S, et al.
Guidelines on penile cancer, EAU 2014.
23. Pávek V, Drábek M, Lavička Z.
Lymfadenektomie sentinelové uzliny epidermoidního karcinomu pro-
staty. Ces Urol 2012, 16(2): 125–128.
24. National Institute for Clinical Excellence (2002) Guidance on cancer services.
Improving outcomes
in urological cancers- the manual. NICE, London: 83–85, také: http://www.nice, org, uk/pdfúUrological_Ma-
nual.pdf.
25. Azif M, Logue JP, Swindell R, et al.
External – beam radiotherapy in T1–T2 N0 penile carcinoma. Clinical
Oncology May 2006; 18(4): 320–325.
26. Franks KN, Kancherla K, Sethugavalar B, et al.
Radiotherapy for node positive penile cancer: experi-
ence of the Leeds teaching hospitals. J. Urol 2011 Aug; 186(2): 524–529.
27. Chaudhari AJ, Ghosh S, Bhalavat RL, et al.
Interstitial brachytherapy in carcinoma of penis. Strahlenth
Oncol 1999; 175: 17–20.
28. Delannes M, Malavaud V, Douchez J, et al.
Iridium-192 interstitial radiation therapy for squamous cell
carcionoma of the penis. Int J Radiat Oncol Biol Phys 1984; 10: 1891–1895.
29. Gerbaulet A, Lambin P, Haie-Mader C, et al.
Brachytherapy of penile cancer. Ann Urol 1994; 28: 306–311.
30. Kanfir K, Haie-Mader C, Abano M, et al.
Outcome of patiens treated with exclusive brachytherapy for
carcinoma of penis: the IGR experience. Clin Oncol 2000; 12: 25–31.